Compare FMNB & AURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FMNB | AURA |
|---|---|---|
| Founded | 1887 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 857.4M | 713.4M |
| IPO Year | 2010 | 2021 |
| Metric | FMNB | AURA |
|---|---|---|
| Price | $16.35 | $7.63 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | $15.00 | ★ $20.00 |
| AVG Volume (30 Days) | 410.3K | ★ 411.3K |
| Earning Date | 04-22-2026 | 05-08-2026 |
| Dividend Yield | ★ 4.89% | N/A |
| EPS Growth | ★ 18.85 | N/A |
| EPS | ★ 0.76 | N/A |
| Revenue | ★ $279,922,000.00 | N/A |
| Revenue This Year | $52.63 | N/A |
| Revenue Next Year | $8.28 | N/A |
| P/E Ratio | $21.25 | ★ N/A |
| Revenue Growth | ★ 3.89 | N/A |
| 52 Week Low | $12.23 | $4.73 |
| 52 Week High | $16.18 | $9.54 |
| Indicator | FMNB | AURA |
|---|---|---|
| Relative Strength Index (RSI) | 72.34 | 56.65 |
| Support Level | $13.75 | $6.65 |
| Resistance Level | N/A | $7.70 |
| Average True Range (ATR) | 0.27 | 0.39 |
| MACD | 0.03 | 0.06 |
| Stochastic Oscillator | 99.62 | 57.86 |
Farmers National Banc Corp is a financial holding company based in the U.S. Along with its subsidiaries, it operates in the domestic banking, trust, retirement consulting, insurance, and financial management industries. The group offers a full range of commercial and retail banking services, including checking accounts, savings accounts, time deposit accounts, commercial, mortgage, and installment loans, safe deposit boxes, ATMs, internet banking, and other banking services. Additionally, it offers personal and corporate trust services in the areas of estate settlement, trust administration, employee benefit plans, and retirement services; insurance products, and other financial products and services. The group's reportable segments are Bank, which generates the maximum revenue, and Trust.
Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.